提出日 |
提出者 |
共同 |
保有割合 |
前回割合 |
増減 |
保有株数 |
11/09/12 |
科研製薬 |
単 |
13.23% |
11.46% |
+1.77% |
13,479,831 |
11/08/10 |
科研製薬 |
単 |
11.46% |
10.42% |
+1.04% |
11,671,078 |
11/05/30 |
科研製薬 |
単 |
10.42% |
9.38% |
+1.04% |
10,612,541 |
10/09/09 |
科研製薬 |
単 |
9.38% |
8.30% |
+1.08% |
9,559,263 |
10/08/25 |
科研製薬 |
単 |
8.30% |
7.22% |
+1.08% |
8,457,730 |
10/07/29 |
科研製薬 |
単 |
7.22% |
6.13% |
+1.09% |
7,352,834 |
10/07/12 |
科研製薬 |
単 |
6.13% |
5.04% |
+1.09% |
6,244,342 |
10/04/05 |
野村證券 |
共 |
4.88% |
5.24% |
-0.36% |
4,972,567 |
10/02/26 |
科研製薬 |
単 |
5.04% |
0.00% |
+5.04% |
5,136,572 |
09/11/18 |
野村アセットマネジメント |
共 |
5.24% |
0.00% |
+5.24% |
5,343,000 |
08/11/21 |
みずほ銀行 |
共 |
5.01% |
0.00% |
+5.01% |
5,108,875 |
08/11/21 |
ソニー生命保険 |
単 |
3.85% |
5.12% |
-1.27% |
3,926,000 |
08/09/04 |
科研製薬 |
単 |
0.62% |
10.93% |
-10.31% |
634,192 |
08/08/20 |
野村證券 |
共 |
4.13% |
5.24% |
-1.11% |
4,750,000 |
08/02/20 |
科研製薬 |
単 |
10.93% |
9.89% |
+1.04% |
12,553,514 |
08/01/23 |
科研製薬 |
単 |
9.89% |
8.86% |
+1.03% |
11,359,271 |
07/12/14 |
科研製薬 |
単 |
8.86% |
7.84% |
+1.02% |
10,179,072 |
07/11/27 |
科研製薬 |
単 |
7.84% |
6.77% |
+1.07% |
9,001,511 |
07/09/20 |
アクサ・ローゼンバーグ証券投信投資顧問 |
単 |
3.03% |
5.66% |
-2.63% |
3,432,000 |
07/08/29 |
科研製薬 |
単 |
6.77% |
5.73% |
+1.04% |
7,769,437 |
|